About 10 results found for searched term "BF-1" (0.103 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1673 | Nintedanib | VEGFR/PDGFR |
| BIBF1120; Intedanib | ||
| Nintedanib (BIBF1120) is a novel, potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50s of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM, respectively. | ||
| M6197 | Nintedanib Ethanesulfonate Salt | VEGFR/PDGFR |
| BIBF 1120 esylate | ||
| BIBF 1120 esylate is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50s of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM, respectively. | ||
| M7639 | BF-170 hydrochloride | Others |
| BF-170 is a new probe for neurofibrillary tangles (tau fibrils). | ||
| M21874 | BIBF 1202 | Others |
| BIBF 1202 | ||
| M21890 | BFCAs-1 | Others |
| BFCAs-1 | ||
| M25037 | Cevostamab | Others |
| BFCR 4350A; RG 6160; RO 7187797 | ||
| Cevostamab (BFCR4350A; RG6160; RO7187797) is a humanized IgG1-based BsAb that targets membrane-proximal extracellular domain of FcRH5 on multiple myeloma (MM) cells as well as CD3 on T cells. Moreover, Cevostamab facilitates efficient synapse formation, improves killing activity of T cells against MM tumor cells. | ||
| M31187 | LS-BF1 | Antibiotic |
| LS-BF1 is a stable and low toxic cationic antimicrobial peptide. LS-BF1 displays broad spectrum of antibacterial activity, including the challenging ESKAPE pathogens, by cell membrane disruptive mechanism. LS-BF1 shows good in vivo efficacy for elimination of bacteria in a mouse infection model. | ||
| M53554 | LS-BF1 | Antibiotic |
| LS-BF1 is a stable and low toxic cationic antimicrobial peptide. | ||
| M53892 | bFGF (119-126) | Others |
| bFGF (119-126) is a biological active peptide. | ||
| M57780 | BF-1 | Others |
| BF-1 | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
